DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 203 filers reported holding DIPLOMAT PHARMACY INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $25,000 | -32.4% | 976 | -46.5% | 0.00% | – |
| Q1 2018 | $37,000 | -2.6% | 1,823 | -4.9% | 0.00% | – |
| Q4 2017 | $38,000 | +72.7% | 1,917 | +77.7% | 0.00% | – |
| Q3 2017 | $22,000 | +37.5% | 1,079 | 0.0% | 0.00% | – |
| Q2 2017 | $16,000 | -5.9% | 1,079 | 0.0% | 0.00% | – |
| Q1 2017 | $17,000 | +21.4% | 1,079 | 0.0% | 0.00% | – |
| Q4 2016 | $14,000 | -60.0% | 1,079 | -14.2% | 0.00% | – |
| Q3 2016 | $35,000 | +12.9% | 1,257 | +44.0% | 0.00% | – |
| Q2 2016 | $31,000 | +34.8% | 873 | +2.8% | 0.00% | – |
| Q1 2016 | $23,000 | -32.4% | 849 | -15.4% | 0.00% | – |
| Q4 2015 | $34,000 | +70.0% | 1,004 | +42.2% | 0.00% | – |
| Q3 2015 | $20,000 | -42.9% | 706 | -9.3% | 0.00% | – |
| Q2 2015 | $35,000 | +105.9% | 778 | +55.6% | 0.00% | – |
| Q1 2015 | $17,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |